Cochrane Abstracts
Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease: Cochrane systematic review
Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Combined Corticosteroid and Long-acting Beta 2 -agonist in One Inhaler Versus Placebo for Chronic Obstructive Pulmonary Disease: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431942/all/Combined_corticosteroid_and_long_acting_beta_2__agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease:_Cochrane_systematic_review. Accessed 13 April 2021.
Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431942/all/Combined_corticosteroid_and_long_acting_beta_2__agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease:_Cochrane_systematic_review. Accessed April 13, 2021.
Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431942/all/Combined_corticosteroid_and_long_acting_beta_2__agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease:_Cochrane_systematic_review
Combined Corticosteroid and Long-acting Beta 2 -agonist in One Inhaler Versus Placebo for Chronic Obstructive Pulmonary Disease: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2021 April 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431942/all/Combined_corticosteroid_and_long_acting_beta_2__agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease: Cochrane systematic review
ID - 431942
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431942/all/Combined_corticosteroid_and_long_acting_beta_2__agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
